DELEVA

Gupta, Sanjeev K.

Application Filed: 2016-06-20

Trademark Application Details

Status

602

Dead/Abandoned

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Research	OneLook Acronym Finder
Serial Number	87077151
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Law Office Assigned	N10
Employee Name	BULLOFF, TOBY ELLEN

Timeline

2016-06-20	Application Filed
2017-10-06	Abandon
2017-11-02	Location: TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED
2017-11-02	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	GUPTA, SANJEEV K.
Address	14 Wyckoff Way Chester NJ US 07930
Legal Entity Type	Individual
Legal Entity State	US

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

GUPTA, SANJEEV K.
14 WYCKOFF WAY
CHESTER, NJ 07930

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	10
U.S. Codes:	026,039,044

Type Code	Type
GS0051	Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for VITAMINS that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for DRUGS that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of PATCHES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of TABLETS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of CAPSULES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of LIQUID DISPERSIONS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of PELLETS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of PARTICLES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of POWDER that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of COATINGS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of GRANULES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of INSERTS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of STENTS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of TUBE that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of ROD that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of FILMS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of SOLUTIONS that facilitate the delivery of pharmaceutical preparations; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for CONTROLLED RELEASE OF DRUG; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Transdermal patches featuring VITAMINS FOR PROMOTING GOOD HEALTH

Type Code

Type

GS0051

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for VITAMINS that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for DRUGS that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of PATCHES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of TABLETS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of CAPSULES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of LIQUID DISPERSIONS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of PELLETS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of PARTICLES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of POWDER that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of COATINGS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of GRANULES that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of INSERTS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of STENTS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of TUBE that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of ROD that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of FILMS that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of SOLUTIONS that facilitate the delivery of pharmaceutical preparations; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for CONTROLLED RELEASE OF DRUG; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Transdermal patches featuring VITAMINS FOR PROMOTING GOOD HEALTH

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2016-06-23	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2016-06-24	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2016-09-27	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2016-10-04	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2016-10-04	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2016-10-04	6 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2016-10-04	7 TROA I:Incoming Correspondence
ASSIGNED TO LIE	2016-10-14	8 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE	2016-10-19	9 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2016-10-19	10 TEME I:Incoming Correspondence
SUSPENSION LETTER WRITTEN	2016-10-28	11 CNSL R:Renewal
LETTER OF SUSPENSION E-MAILED	2016-10-28	12 GNSL S:
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	2016-10-28	13 GNS3 O:Outgoing Correspondence
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED	2017-03-20	14 ERSI I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2017-03-20	15 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2017-03-21	16 TEME I:Incoming Correspondence
NON-FINAL ACTION WRITTEN	2017-04-05	17 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2017-04-05	18 GNRT O:Outgoing Correspondence
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2017-04-05	19 GNRN O:Outgoing Correspondence
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	2017-11-02	20 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	2017-11-02	21 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.